Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
01:46pm, Friday, 07'th Nov 2025
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Insulet Corp (PODD) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amidst Rising Competition
04:04pm, Thursday, 06'th Nov 2025
Quarterly Revenue: Surpassed $700 million, marking a 28% year-over-year growth at constant currency rates.Operating Margin: Expanded by 90 basis points year-ov
Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript
12:46pm, Thursday, 06'th Nov 2025
Insulet Corporation ( PODD ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Clare Trachtman - Vice President of Investor Relations Ashley McEvoy - CEO, President & Director Fl
Insulet (PODD) Reports Q3 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 06'th Nov 2025
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compa
Insulet (PODD) Q3 Earnings and Revenues Beat Estimates
08:40am, Thursday, 06'th Nov 2025
Insulet (PODD) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $0.9 per share a year ago.
Insulet Corp (PODD) Q3 2025 Earnings: EPS of $1.24 Beats Estimate, Revenue Surges to $706.3 Million
07:32am, Thursday, 06'th Nov 2025
Revenue: Achieved $706.3 million, surpassing the estimated $676.73 million, marking a 29.9% increase year-over-year.Earnings Per Share (EPS): Reported at $1.24
Insulet tops quarterly estimates on demand for wearable insulin pumps
07:29am, Thursday, 06'th Nov 2025
Medical device maker Insulet on Thursday posted third-quarter results that surpassed Wall Street's expectations on strong demand for its wearable insulin pumps, which eliminate the need for daily inje
Insulet Reports Third Quarter 2025 Results
06:30am, Thursday, 06'th Nov 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Final Trades: Insulet Corp, Uber and Apollo Global
01:20pm, Tuesday, 04'th Nov 2025
The Investment Committee give you their top stocks to watch for the second half.
Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Tuesday, 04'th Nov 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Insulet (PODD), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Insulet (PODD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 30'th Oct 2025
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
04:00am, Thursday, 30'th Oct 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet Corporation $PODD Shares Bought by DekaBank Deutsche Girozentrale
06:07am, Sunday, 26'th Oct 2025
DekaBank Deutsche Girozentrale raised its holdings in Insulet Corporation (NASDAQ: PODD) by 1.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the Secu
Chicago Partners Investment Group LLC Makes New Investment in Insulet Corporation $PODD
05:14am, Sunday, 26'th Oct 2025
Chicago Partners Investment Group LLC acquired a new position in Insulet Corporation (NASDAQ: PODD) during the second quarter, according to its most recent filing with the Securities and Exchange Comm
Insulet Announces Appointment of Robert L. Huffines to its Board of Directors
07:00am, Thursday, 23'rd Oct 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
